tiprankstipranks
Sundrug Co Ltd (JP:9989)
:9989
Japanese Market
9989
Sundrug Co
RESEARCH TOOLSreports
Want to see JP:9989 full AI Analyst Report?

Sundrug Co (9989) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

9989 Analyst Ratings

Hold
4Ratings
Hold
1 Buy
3 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Sundrug
Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

9989 Stock 12 Month Forecast

Average Price Target

¥4,405.00
▲(6.48% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Sundrug Co in the last 3 months. The average price target is ¥4,405.00 with a high forecast of ¥5,100.00 and a low forecast of ¥3,920.00. The average price target represents a 6.48% change from the last price of ¥4,137.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3599":"¥3,599","4350":"¥4,350","5101":"¥5,101","3974.5":"¥3,974.5","4725.5":"¥4,725.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥5.10K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4405,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥4.41K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3920,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥3.92K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3599,3974.5,4350,4725.5,5101],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3600,3715.3846153846152,3830.769230769231,3946.153846153846,4061.5384615384614,4176.923076923077,4292.307692307692,4407.692307692308,4523.076923076923,4638.461538461539,4753.846153846154,4869.2307692307695,4984.615384615385,{"y":5100,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3600,3661.923076923077,3723.846153846154,3785.769230769231,3847.6923076923076,3909.6153846153848,3971.5384615384614,4033.4615384615386,4095.3846153846152,4157.307692307692,4219.2307692307695,4281.153846153846,4343.076923076923,{"y":4405,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3600,3624.6153846153848,3649.230769230769,3673.846153846154,3698.4615384615386,3723.076923076923,3747.6923076923076,3772.3076923076924,3796.923076923077,3821.5384615384614,3846.153846153846,3870.769230769231,3895.3846153846152,{"y":3920,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4304.633,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4353.076,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4413.145,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4524.563,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4175.73,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4090.19,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4212.11,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4233.74,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4073.475,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4168.848,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3946,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3764,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3600,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target¥5,100Average Price Target¥4,405Lowest Price Target¥3,920
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
SMBC Nikko Analyst forecast on JP:9989
Unknown Analyst
SMBC Nikko
Not Ranked
SMBC Nikko
¥4,200
Hold
1.52%
Upside
Reiterated
06/03/26
SMBC Nikko Reaffirms Their Hold Rating on Sundrug Co (SDGCF)
UBS Analyst forecast on JP:9989
Unknown Analyst
UBS
Not Ranked
UBS
¥4,260→¥3,920
Hold
-5.25%
Downside
Reiterated
05/27/26
Sundrug Co (SDGCF) Gets a Hold from UBS
Mizuho Securities Analyst forecast on JP:9989
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
¥5,100
Buy
23.28%
Upside
Reiterated
05/22/26
Mizuho Securities Sticks to Its Buy Rating for Sundrug Co (SDGCF)
J.P. Morgan Analyst forecast on JP:9989
Dairo Murata
J.P. Morgan
J.P. Morgan
¥4,500→¥4,400
Hold
6.36%
Upside
Reiterated
04/13/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sundrug Co (Other OTC: SDGCF) and Verastem (NASDAQ: VSTM)
Iwai Cosmo Analyst forecast on JP:9989
Unknown Analyst
Iwai Cosmo
Not Ranked
Iwai Cosmo
¥5,400
Buy
30.53%
Upside
Reiterated
12/12/25
Nomura Analyst forecast on JP:9989
Hisahiro Yamaoka
Nomura
Nomura
¥5,600
Buy
35.36%
Upside
Reiterated
12/01/25
Macquarie Analyst forecast on JP:9989
Natsuko Douglas
Macquarie
Macquarie
¥5,200→¥5,600
Buy
35.36%
Upside
Reiterated
07/21/25
Macquarie Keeps Their Buy Rating on Sundrug Co (SDGCF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
SMBC Nikko Analyst forecast on JP:9989
Unknown Analyst
SMBC Nikko
Not Ranked
SMBC Nikko
¥4,200
Hold
1.52%
Upside
Reiterated
06/03/26
SMBC Nikko Reaffirms Their Hold Rating on Sundrug Co (SDGCF)
UBS Analyst forecast on JP:9989
Unknown Analyst
UBS
Not Ranked
UBS
¥4,260→¥3,920
Hold
-5.25%
Downside
Reiterated
05/27/26
Sundrug Co (SDGCF) Gets a Hold from UBS
Mizuho Securities Analyst forecast on JP:9989
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
¥5,100
Buy
23.28%
Upside
Reiterated
05/22/26
Mizuho Securities Sticks to Its Buy Rating for Sundrug Co (SDGCF)
J.P. Morgan Analyst forecast on JP:9989
Dairo Murata
J.P. Morgan
J.P. Morgan
¥4,500→¥4,400
Hold
6.36%
Upside
Reiterated
04/13/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sundrug Co (Other OTC: SDGCF) and Verastem (NASDAQ: VSTM)
Iwai Cosmo Analyst forecast on JP:9989
Unknown Analyst
Iwai Cosmo
Not Ranked
Iwai Cosmo
¥5,400
Buy
30.53%
Upside
Reiterated
12/12/25
Nomura Analyst forecast on JP:9989
Hisahiro Yamaoka
Nomura
Nomura
¥5,600
Buy
35.36%
Upside
Reiterated
12/01/25
Macquarie Analyst forecast on JP:9989
Natsuko Douglas
Macquarie
Macquarie
¥5,200→¥5,600
Buy
35.36%
Upside
Reiterated
07/21/25
Macquarie Keeps Their Buy Rating on Sundrug Co (SDGCF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sundrug Co

3 Months
Natsuko DouglasMacquarie
Success Rate
1/2 ratings generated profit
50%
Average Return
+0.65%
Copying Natsuko Douglas's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +0.65% per trade.
1 Year
Natsuko DouglasMacquarie
Success Rate
1/2 ratings generated profit
50%
Average Return
-5.60%
Copying Natsuko Douglas's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -5.60% per trade.
2 Years
xAi Medical - PharmaceuticalsTipRanks - xAI
Success Rate
0/2 ratings generated profit
0%
Average Return
-10.45%
Copying xAi Medical - Pharmaceuticals's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -10.45% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

9989 Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
3
1
1
1
1
Hold
3
3
3
3
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
4
4
4
5
In the current month, 9989 has received 1 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. 9989 average Analyst price target in the past 3 months is 4,405.00.
Each month's total comprises the sum of three months' worth of ratings.

9989 Financial Forecast

9989 Earnings Forecast

Next quarter’s earnings estimate for 9989 is ¥70.73 with a range of ¥70.73 to ¥70.73. The previous quarter’s EPS was ¥61.21. 9989 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 9989 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 9989 is ¥70.73 with a range of ¥70.73 to ¥70.73. The previous quarter’s EPS was ¥61.21. 9989 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 9989 has Performed in-line its overall industry.

9989 Sales Forecast

Next quarter’s sales forecast for 9989 is ¥217.60B with a range of ¥216.48B to ¥219.50B. The previous quarter’s sales results were ¥206.81B. 9989 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 9989 has Performed in-line its overall industry.
Next quarter’s sales forecast for 9989 is ¥217.60B with a range of ¥216.48B to ¥219.50B. The previous quarter’s sales results were ¥206.81B. 9989 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 9989 has Performed in-line its overall industry.

9989 Stock Forecast FAQ

What is JP:9989’s average 12-month price target, according to analysts?
Based on analyst ratings, Sundrug Co Ltd’s 12-month average price target is 4,405.00.
    What is JP:9989’s upside potential, based on the analysts’ average price target?
    Sundrug Co Ltd has 6.48% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Sundrug Co Ltd a Buy, Sell or Hold?
          Sundrug Co Ltd has a consensus rating of Hold, which is based on 1 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Sundrug Co Ltd’s share price target?
            The average share price target for Sundrug Co Ltd is 4,405.00. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is ¥5,100.00 ,and the lowest forecast is ¥3,920.00. The average share price target represents 6.48% Increase from the current price of ¥4,137.
              What do analysts say about Sundrug Co Ltd?
              Sundrug Co Ltd’s analyst rating consensus is a Hold. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of Sundrug Co Ltd?
                To buy shares of JP:9989, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.